Livmor has won a nod from FDA for a physician-prescribed wearable that continuously monitors for atrial fibrillation. The Dallas, TX-based company said continuous monitoring can significantly enhance the detection of paroxysmal (intermittent) or asymptomatic forms of Afib.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,